Neonc Technologies Holdings, Inc. (NTHI): Total Assets
$2.82M
As of 2025-12-31
$5.23M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.82M | -17.4% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $3.42M | n/a | 2026-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $340.05M | -30.7% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $17.41M | -14.2% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $29.72M | +63.0% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
Compare NTHI, ALT, LYEL, IBO side by side · Screen every company in Pharmaceutical Preparations ↗